BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

827 related articles for article (PubMed ID: 20106948)

  • 1. Kynurenic acid is a potent endogenous aryl hydrocarbon receptor ligand that synergistically induces interleukin-6 in the presence of inflammatory signaling.
    DiNatale BC; Murray IA; Schroeder JC; Flaveny CA; Lahoti TS; Laurenzana EM; Omiecinski CJ; Perdew GH
    Toxicol Sci; 2010 May; 115(1):89-97. PubMed ID: 20106948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aryl hydrocarbon receptor-dependence of dioxin's effects on constitutive mouse hepatic cytochromes P450 and growth hormone signaling components.
    Lee C; Riddick DS
    Can J Physiol Pharmacol; 2012 Oct; 90(10):1354-63. PubMed ID: 22978700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction between halogenated aromatic compounds in the Ah receptor signal transduction pathway.
    Chen G; Bunce NJ
    Environ Toxicol; 2004 Oct; 19(5):480-9. PubMed ID: 15352264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome-wide RNAi high-throughput screen identifies proteins necessary for the AHR-dependent induction of CYP1A1 by 2,3,7,8-tetrachlorodibenzo-p-dioxin.
    Solaimani P; Damoiseaux R; Hankinson O
    Toxicol Sci; 2013 Nov; 136(1):107-19. PubMed ID: 23997114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A potential endogenous ligand for the aryl hydrocarbon receptor has potent agonist activity in vitro and in vivo.
    Henry EC; Bemis JC; Henry O; Kende AS; Gasiewicz TA
    Arch Biochem Biophys; 2006 Jun; 450(1):67-77. PubMed ID: 16545771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cooperation of structurally different aryl hydrocarbon receptor agonists and β-catenin in the regulation of CYP1A expression.
    Vaas S; Kreft L; Schwarz M; Braeuning A
    Toxicology; 2014 Nov; 325():31-41. PubMed ID: 25174530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mixed-ligand copper(II) complexes activate aryl hydrocarbon receptor AhR and induce CYP1A genes expression in human hepatocytes and human cell lines.
    Kubešová K; Dořičáková A; Trávníček Z; Dvořák Z
    Toxicol Lett; 2016 Jul; 255():24-35. PubMed ID: 27180721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The glycogen synthase kinase inhibitor 3-(2,4-dichlorophenyl)-4-(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione (SB216763) is a partial agonist of the aryl hydrocarbon receptor.
    Braeuning A; Buchmann A
    Drug Metab Dispos; 2009 Aug; 37(8):1576-80. PubMed ID: 19448134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The uremic toxin 3-indoxyl sulfate is a potent endogenous agonist for the human aryl hydrocarbon receptor.
    Schroeder JC; Dinatale BC; Murray IA; Flaveny CA; Liu Q; Laurenzana EM; Lin JM; Strom SC; Omiecinski CJ; Amin S; Perdew GH
    Biochemistry; 2010 Jan; 49(2):393-400. PubMed ID: 20000589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pelargonidin activates the AhR and induces CYP1A1 in primary human hepatocytes and human cancer cell lines HepG2 and LS174T.
    Kamenickova A; Anzenbacherova E; Pavek P; Soshilov AA; Denison MS; Anzenbacher P; Dvorak Z
    Toxicol Lett; 2013 Apr; 218(3):253-9. PubMed ID: 23419638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel roles for AhR and ARNT in the regulation of alcohol dehydrogenases in human hepatic cells.
    Attignon EA; Leblanc AF; Le-Grand B; Duval C; Aggerbeck M; Rouach H; Blanc EB
    Arch Toxicol; 2017 Jan; 91(1):313-324. PubMed ID: 27055685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for an aryl hydrocarbon receptor-mediated cytochrome p450 autoregulatory pathway.
    Chiaro CR; Patel RD; Marcus CB; Perdew GH
    Mol Pharmacol; 2007 Nov; 72(5):1369-79. PubMed ID: 17720764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors activate the aryl hydrocarbon receptor.
    Moyer BJ; Rojas IY; Murray IA; Lee S; Hazlett HF; Perdew GH; Tomlinson CR
    Toxicol Appl Pharmacol; 2017 May; 323():74-80. PubMed ID: 28336214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mono-methylindoles induce CYP1A genes and inhibit CYP1A1 enzyme activity in human hepatocytes and HepaRG cells.
    Vyhlídalová B; Poulíková K; Bartoňková I; Krasulová K; Vančo J; Trávníček Z; Mani S; Dvořák Z
    Toxicol Lett; 2019 Oct; 313():66-76. PubMed ID: 31201936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Editor's Highlight: Ah Receptor Activation Potentiates Neutrophil Chemoattractant (C-X-C Motif) Ligand 5 Expression in Keratinocytes and Skin.
    Smith KJ; Boyer JA; Muku GE; Murray IA; Gowda K; Desai D; Amin SG; Glick AB; Perdew GH
    Toxicol Sci; 2017 Nov; 160(1):83-94. PubMed ID: 28973351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aryl hydrocarbon receptor ligand effects in RBL2H3 cells.
    Maaetoft-Udsen K; Shimoda LM; Frøkiær H; Turner H
    J Immunotoxicol; 2012; 9(3):327-37. PubMed ID: 22471748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of aryl hydrocarbon receptor in basal and 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced expression of target genes in primary human hepatocytes.
    Le Vee M; Jouan E; Fardel O
    Toxicol In Vitro; 2010 Sep; 24(6):1775-81. PubMed ID: 20619336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. JNK inhibitor SP600125 is a partial agonist of human aryl hydrocarbon receptor and induces CYP1A1 and CYP1A2 genes in primary human hepatocytes.
    Dvorak Z; Vrzal R; Henklova P; Jancova P; Anzenbacherova E; Maurel P; Svecova L; Pavek P; Ehrmann J; Havlik R; Bednar P; Lemr K; Ulrichova J
    Biochem Pharmacol; 2008 Jan; 75(2):580-8. PubMed ID: 17959153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential ligand-dependent activation and a role for Y322 in aryl hydrocarbon receptor-mediated regulation of gene expression.
    Powis M; Celius T; Matthews J
    Biochem Biophys Res Commun; 2011 Jul; 410(4):859-65. PubMed ID: 21703235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crosstalk between the aryl hydrocarbon receptor and hypoxia on the constitutive expression of cytochrome P4501A1 mRNA.
    Zhang N; Walker MK
    Cardiovasc Toxicol; 2007; 7(4):282-90. PubMed ID: 17968679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.